Highlights from The North American Menopause Society 25th Annual Meeting
JDS Therapeutics, LLC, an innovative specialty pharmaceutical company focused on providing patients with scientifically backed, natural approaches to meet their healthcare needs, announces that its product Relizen®, a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause, was included in two scientific posters presented at this year’s annual meeting of The North American Menopause Society (NAMS).
The two posters were titled “Does Relizen, a non-hormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?” and “How can hot flashes be managed for breast cancer patients and survivors without risk?” The former was presented by Steven R. Goldstein, MD, FACOG, NCMP of New York City and the latter by Professor René Druckmann, MD, OBGYN of Nice, France. Abstracts from these posters will be published in the December issue of the Menopause journal, the official publication of NAMS.
Read the full press release here – http://www.prweb.com/releases/2014/10/prweb12289158.htm
To find out more about Relizen, visit http://www.Relizen.com